These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 1424192)

  • 1. Effect of menopause and hormone replacement therapy on urinary excretion of pyridinium cross-links: a longitudinal and cross-sectional study.
    Hassager C; Colwell A; Assiri AM; Eastell R; Russell RG; Christiansen C
    Clin Endocrinol (Oxf); 1992 Jul; 37(1):45-50. PubMed ID: 1424192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary excretion of pyridinium cross-links in healthy women; the long-term effects of menopause and oestrogen/progesterone therapy.
    Schlemmer A; Hassager C; Delmas PD; Christiansen C
    Clin Endocrinol (Oxf); 1994 Jun; 40(6):777-82. PubMed ID: 8033369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of hormone replacement therapy on the bone mass and urinary excretion of pyridinium cross-links.
    Pardini DP; Sabino AT; Meneses AM; Kasamatsu T; Vieira JG
    Sao Paulo Med J; 2000 Jan; 118(1):3-6. PubMed ID: 10685120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary excretion of pyridinoline and deoxypyridinoline measured by immunoassay in hypothyroidism.
    Nakamura H; Mori T; Genma R; Suzuki Y; Natsume H; Andoh S; Kitahara R; Nagasawa S; Nishiyama K; Yoshimi T
    Clin Endocrinol (Oxf); 1996 Apr; 44(4):447-51. PubMed ID: 8706312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links.
    Uebelhart D; Schlemmer A; Johansen JS; Gineyts E; Christiansen C; Delmas PD
    J Clin Endocrinol Metab; 1991 Feb; 72(2):367-73. PubMed ID: 1991806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of transdermal 17 beta-estradiol and oral conjugated equine estrogens on biochemical parameters of bone resorption in natural menopause.
    Reginster JY; Christiansen C; Dequinze B; Deroisy R; Gaspard U; Taquet AN; Franchimont P
    Calcif Tissue Int; 1993 Jul; 53(1):13-6. PubMed ID: 8394191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary pyridinoline and deoxypyridinoline excretion in children.
    Shaw NJ; Dutton J; Fraser WD; Smith CS
    Clin Endocrinol (Oxf); 1995 Jun; 42(6):607-12. PubMed ID: 7634501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone turnover markers and bone density across the menopausal transition.
    Ebeling PR; Atley LM; Guthrie JR; Burger HG; Dennerstein L; Hopper JL; Wark JD
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3366-71. PubMed ID: 8784098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between female sex hormones and biochemical markers of bone turnover in peri- and postmenopausal women.
    Peichl P; Griesmacher A; Pointinger P; Marteau R; Hartl W; Gruber W; Bröll H
    Calcif Tissue Int; 1998 May; 62(5):388-94. PubMed ID: 9541515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of growth hormone (GH) therapy on urinary pyridinoline cross-links in GH-deficient adults.
    Schlemmer A; Johansen JS; Pedersen SA; Jørgensen JO; Hassager C; Christiansen C
    Clin Endocrinol (Oxf); 1991 Dec; 35(6):471-6. PubMed ID: 1769127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum osteocalcin and urinary crosslaps are suitable markers of bone turnover in response to short-term hormone replacement therapy.
    Peichl P; Griesmacher A; Müller MM; Marteau R; Kumpan W; Bröll H
    Gynecol Endocrinol; 2000 Oct; 14(5):374-81. PubMed ID: 11109977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical markers in menopausal women.
    Griesmacher A; Peichl P; Pointinger P; Mateau R; Bröll H; Hartl W; Gruber W
    Scand J Clin Lab Invest Suppl; 1997; 227():64-72. PubMed ID: 9127469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A longitudinal study of bone-related biochemical changes at the menopause.
    Nordin BE; WIshart JM; Clifton PM; McArthur R; Scopacasa F; Need AG; Morris HA; O'Loughlin PD; Horowitz M
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):123-30. PubMed ID: 15212654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitation of urinary hydroxypyridinium cross-links from collagen by high-performance liquid chromatography.
    Kollerup G; Thamsborg G; Bhatia H; Sørensen OH
    Scand J Clin Lab Invest; 1992 Nov; 52(7):657-62. PubMed ID: 1455159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study.
    Morabito N; Crisafulli A; Vergara C; Gaudio A; Lasco A; Frisina N; D'Anna R; Corrado F; Pizzoleo MA; Cincotta M; Altavilla D; Ientile R; Squadrito F
    J Bone Miner Res; 2002 Oct; 17(10):1904-12. PubMed ID: 12369794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marked diurnal variation in urinary excretion of pyridinium cross-links in premenopausal women.
    Schlemmer A; Hassager C; Jensen SB; Christiansen C
    J Clin Endocrinol Metab; 1992 Mar; 74(3):476-80. PubMed ID: 1740479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased bone mineral density associated with early menopause progresses for at least ten years: cross-sectional comparisons between early and normal menopausal women.
    Ohta H; Sugimoto I; Masuda A; Komukai S; Suda Y; Makita K; Takamatsu K; Horiguchi F; Nozawa S
    Bone; 1996 Mar; 18(3):227-31. PubMed ID: 8703577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary bone resorption markers in patients with metabolic bone disorders.
    Ohishi T; Kushida K; Takahashi M; Kawana K; Yagi K; Kawakami K; Horiuchi K; Inoue T
    Bone; 1994; 15(1):15-20. PubMed ID: 8024845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collagen cross-link metabolites in urine as markers of bone metastases in prostatic carcinoma.
    Miyamoto KK; McSherry SA; Robins SP; Besterman JM; Mohler JL
    J Urol; 1994 Apr; 151(4):909-13. PubMed ID: 7510346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in urinary excretion of type-I collagen cross-linked C-telopeptide and N-telopeptide in perimenopausal women.
    Taga M; Shirashu K; Minaguchi H
    Horm Res; 1998; 49(2):86-90. PubMed ID: 9485177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.